申请人:WEST LIBERTY UNIVERSITY
公开号:US20220040146A1
公开(公告)日:2022-02-10
A pharmaceutical composition is provided that comprises an effective amount of dillapiole or a derivative thereof, and a pharmaceutically-acceptable vehicle, carrier, or excipient. Methods of treating a bacterial infection are also described and include administering an effective amount of dillapiole or a derivative thereof to a subject in need of such treatment. Methods of reducing bacterial virulence are further described and include contacting a bacterium, such as a
F. tularensis
or
A. baumannii
bacterium, with an effective amount of dillapiole or a derivative thereof.